{"disease":{"id":"pharmacodynamics","name":"pharmacodynamics"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04684056","title":"Laboratory Assessment of the Concentration of Direct Oral Anticoagulants in Patients With Atrial Fibrillation","phase":"","overall_status":"UNKNOWN","enrollment_count":1864,"lead_sponsor_name":"Wuhan Asia Heart Hospital","has_results":false},{"nct_id":"NCT01226316","title":"Safety, Tolerability & Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment Schedules","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":285,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT03813875","title":"Modeling and Application of Triple Drug Response Surface Models","phase":"","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Taipei Veterans General Hospital, Taiwan","has_results":false},{"nct_id":"NCT04250038","title":"Association of Cefepime Trough Levels With Clinical Efficacy and Neurotoxicity in Patients With Febrile Neutropenia","phase":"","overall_status":"UNKNOWN","enrollment_count":98,"lead_sponsor_name":"Universitaire Ziekenhuizen KU Leuven","has_results":false},{"nct_id":"NCT02303574","title":"Single + Multiple Ascending Dose and Food Effect Study of AZD7986 in Healthy Volunteers, PK, PD and Safety Study","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":89,"lead_sponsor_name":"AstraZeneca","has_results":true},{"nct_id":"NCT04183491","title":"Pharmacodynamic Biomarkers to Support Biosimilar Development: Interferon Beta-1A Products","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":84,"lead_sponsor_name":"Food and Drug Administration (FDA)","has_results":true},{"nct_id":"NCT04911270","title":"Clinical Decision Support Tool for Vancomycin Dosing in Children","phase":"NA","overall_status":"COMPLETED","enrollment_count":75,"lead_sponsor_name":"University of Maryland, Baltimore","has_results":false},{"nct_id":"NCT04183192","title":"Pharmacodynamic Biomarkers to Support Biosimilar Development: Interleukin-5 Antagonists","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":72,"lead_sponsor_name":"Food and Drug Administration (FDA)","has_results":true},{"nct_id":"NCT07202663","title":"Study of BB-025, Alone and After BB-031, in Healthy Volunteers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":72,"lead_sponsor_name":"Basking Biosciences, Inc.","has_results":false},{"nct_id":"NCT02512575","title":"A Single Ascending Dose Study To Assess The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of AZD9567.","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":72,"lead_sponsor_name":"AstraZeneca","has_results":true},{"nct_id":"NCT04189484","title":"Pharmacodynamic Biomarkers to Support Biosimilar Development: PCSK9 Inhibitors","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":72,"lead_sponsor_name":"Food and Drug Administration (FDA)","has_results":true},{"nct_id":"NCT07237477","title":"Reevaluation Prediction of the Effect Site Propofol Eleveld Model Using Slow and Fast Induction","phase":"","overall_status":"COMPLETED","enrollment_count":70,"lead_sponsor_name":"Pablo O. Sepulveda","has_results":false},{"nct_id":"NCT05539872","title":"Comparison of the Pharmacokinetics (PK) and Pharmacodynamics (PD) Biosimilarity of Proposed Biosimilar Rapid-Acting Insulin Aspart (I004) and NovoLog After Single-Dose Subcutaneous Administration to Healthy Volunteers","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":69,"lead_sponsor_name":"Amphastar Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT05795192","title":"SB17170 Phase1 Trial in Healthy Volunteer","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":64,"lead_sponsor_name":"SPARK Biopharma","has_results":false},{"nct_id":"NCT06993636","title":"Pharmacometrics Analysis of Rivaroxaban in Chinese Children Aged Over 2 Years","phase":"","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Children's Hospital of Fudan University","has_results":false},{"nct_id":"NCT03070470","title":"CiPA Phase 1 ECG Biomarker Validation Study","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Food and Drug Administration (FDA)","has_results":true},{"nct_id":"NCT05153837","title":"Effect of Oral Water in Healthy Volunteers on Cardiac Output, Regional Flow and Microcirculation in Healthy Volunteers","phase":"NA","overall_status":"COMPLETED","enrollment_count":59,"lead_sponsor_name":"Centre Hospitalier Universitaire, Amiens","has_results":false},{"nct_id":"NCT05652595","title":"Double-blind, Randomized Comparative Cross-sectional Study of Pharmacodynamics and Pharmacokinetics of Drugs GP40141","phase":"PHASE1","overall_status":"UNKNOWN","enrollment_count":56,"lead_sponsor_name":"Geropharm","has_results":false},{"nct_id":"NCT06725992","title":"Study to Evaluate Pharmacokinetic and Pharmacodynamic Drug Interactions and Safety of IY-NS250 and IY-NT-SR","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":56,"lead_sponsor_name":"Il-Yang Pharm. Co., Ltd.","has_results":false},{"nct_id":"NCT02218099","title":"A Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of ASP8232 in Subjects With Renal Impairment and in Type 2 Diabetes Mellitus Subjects With Chronic Kidney Disease","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":55,"lead_sponsor_name":"Astellas Pharma Europe B.V.","has_results":false},{"nct_id":"NCT03609853","title":"Behavioral Pharmacology of THC and D-limonene","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":53,"lead_sponsor_name":"Johns Hopkins University","has_results":true},{"nct_id":"NCT05005520","title":"Study of DTRI-031 in Healthy Volunteers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":46,"lead_sponsor_name":"Basking Biosciences, Inc.","has_results":false},{"nct_id":"NCT05716854","title":"Electrophysiological Effects of Potential QT Prolonging Drugs","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":44,"lead_sponsor_name":"Food and Drug Administration (FDA)","has_results":false},{"nct_id":"NCT06072170","title":"Single Ascending Doses of Kratom in Healthy Nondependent Adults With Opioid Experience","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Altasciences Company Inc.","has_results":true},{"nct_id":"NCT04100759","title":"A Comparative Pharmacokinetic and Pharmacodynamic Study of Sildenafil in Adult Smokers and Non Smokers","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"Ain Shams University","has_results":false},{"nct_id":"NCT03895229","title":"The Effect of Morning Versus Evening Administration on The Pharmacokinetics and Pharmacodynamics of Empagliflozin","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":16,"lead_sponsor_name":"Ain Shams University","has_results":false},{"nct_id":"NCT06640569","title":"Preliminary Characterization of Commercial Kratom Extract Products","phase":"","overall_status":"RECRUITING","enrollment_count":16,"lead_sponsor_name":"Johns Hopkins University","has_results":false},{"nct_id":"NCT03378284","title":"A Study to Evaluate Safety, Tolerability, and PD of Tegoprazan on Healthy Male Volunteers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":16,"lead_sponsor_name":"HK inno.N Corporation","has_results":false},{"nct_id":"NCT06469450","title":"KF2023#1-Trial: Influence of Statin Intake on Cellular Readouts","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":15,"lead_sponsor_name":"Mikko Niemi","has_results":false},{"nct_id":"NCT01872026","title":"Examination of Plasma Concentrations and Safety in Chronic Kidney Disease Patients Undergoing Hemodialysis","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":14,"lead_sponsor_name":"Astellas Pharma Inc","has_results":false},{"nct_id":"NCT03121339","title":"Pharmacodynamic Open-Label Trial With VXA-A1.1 Oral H1 Vaccine in Healthy Adults","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":8,"lead_sponsor_name":"Vaxart","has_results":false}],"total":31},"guidelines":[],"source":"Drug Landscape verified database"}